A New Case of Familial Partial Generalized Resistance to Thyroid Hormones: Study of 3,5,3′-Triiodothyronine (T3) Binding to Lymphocyte and Skin Fibroblast Nuclei andin VivoConversion of Thyroxine to T3*
A clinically euthyroid 30-yr-old man with high serum levels of both total (T4,14.5 μg/dl; T3, 272 ng/dl) and free (FT4) 33 pg/ml; FT3, 9.7 pg/ml) thyroid hormones and inappropriately normal TSH levels, both basally and after TRH stimulation, is described. Peripheral indices of thyroid hormone action and the patient's clinical status were not modified by the prolonged administration of supraphysiological doses of both T4 (up to 900 µg/day) and T3 (up to 80 μg/day), which decreased but did not completely abolish the TSH response to TRH. However, the TSH response to TRH was normally blunted by dexamethasone administration, which also reduced serum T4 and T3 levels to normal. T3 binding to nuclei of mononuclear leukocytes and cultured skin fibroblasts was normal. The overall pattern demonstrates that the patient was affected by partial peripheral resistance to thyroid hormone action. Study of the patient's family revealed the same hormone pattern in the patient's father, suggesting an autosomal dominant mode of inheritance. An in vivo study performed after the iv injection of tracer doses of [125I]T4 and [131I]T3, demonstrated increased production rates (PR) of both T4 [PR, 113.0 μg/day-m2; normal subjects, 55.4 ± 12.3 (mean ± SD); n = 13] and T3 (PR, 41.1 Mg/day-m2; normal subjects, 16.3 ± 2.7). In vivo conversion of T4 to T3 was also evaluated in the patient; a nearly normal T4 to T3 conversion factor was found (0.3108 vs. 0.2576 ± 0.0422 in normal subjects). In four hyperthyroid patients, the T4 to T3 conversion factors were similar (0.2932 ± 0.0600), while the PRs of T4 and T3 were increased (PR of T4, 308.6 ± 85.6; PR of T3, 110.3 ± 35.0 μg/ day-m2) compared to those in the normal subjects.